# P1 V7 Work Session Completion — 11 January 2026

**Date:** January 11, 2026  
**Duration:** Full day session  
**Status:** ✅ **ALL TASKS COMPLETE**  
**Final Time:** 19:56

---

## Executive Summary

Successfully completed all enhancement passes for P1 V7 manuscript. The manuscript is now **READY FOR JCIM SUBMISSION** pending only ORCID iDs for 4 co-authors (to be entered during Paragon Plus online submission).

**Final Package Status:**
- ✅ Main manuscript: 25 pages, 0 errors
- ✅ Supporting Information: 17 pages, 0 errors
- ✅ Cover letter: 2 pages, 0 errors (refined)
- ✅ Submission package: Complete and ready
- ⚠️ ORCID iDs: 1/5 (corresponding author provided, 4 co-authors needed)

---

## Tasks Completed Today

### Phase 1: V5 Integration (Validation Documentation)
**Time:** Morning session  
**Status:** ✅ Complete

**Actions:**
1. Created 3 validation tables from V5 content:
   - `sm_table_enrichment_validation.tex` (DEKOIS 2.0 + MMV Malaria Box)
   - `sm_table_redocking_validation.tex` (5 ligands, RMSD values)
   - `sm_table_validation_datasets.tex` (Summary of 3 validation types)

2. Added new SM Section S11 (later renumbered to S12):
   - S11.1: External benchmark validation
   - S11.2: Positive-control enrichment validation
   - S11.3: Redocking validation
   - S11.4: Interpretation and limitations

3. Updated main manuscript cross-reference to new validation section

**Results:**
- SM expanded by +3 pages (10 → 13 pages after this phase)
- Main: 25 pages, SM: 13 pages
- Compilation: 0 errors, 0 undefined references

---

### Phase 2: V7 Promotion to Canonical Version
**Time:** Mid-morning  
**Status:** ✅ Complete

**Actions:**
1. Updated `AGENTS.md`:
   - V7 declared as canonical JCIM submission version
   - V6 moved to archive status
   - Comprehensive V7 description added

2. Created submission package directory `submission_ACS_P1V7/`:
   - Copied main PDF (25 pages, 449 KB)
   - Copied SM PDF (13 pages, 504 KB at this stage)
   - Copied bibliography files (.bbl)
   - Copied auxiliary files (.aux)

3. Created promotion documentation:
   - `P1_V7_PROMOTION_SUMMARY.md`
   - `SUBMISSION_MANIFEST_V7.md` (v1.0)
   - `V7_PROMOTION_PLAN.md`

**Results:**
- V7 officially designated as canonical submission version
- Complete submission package ready
- Documentation trail established

---

### Phase 3: Pre-Submission Requirements
**Time:** Midday  
**Status:** ✅ Complete

**Actions:**
1. **Cover Letter Created:**
   - Comprehensive 2-page cover letter highlighting V7 enhancements
   - Compiled successfully (145 KB PDF)
   - File: `manuscript/Cover_Letter_P1_V7.tex`

2. **ORCID iD Procedure:**
   - User provided corresponding author ORCID: 0009-0004-5170-2309
   - Discovered ACS journals do NOT accept ORCID in LaTeX source
   - Created comprehensive guide: `ORCID_SUBMISSION_INSTRUCTIONS.md`
   - ORCID iDs must be entered in Paragon Plus web form

3. **Funding Acknowledgment:**
   - User stated "No funding to acknowledge"
   - Added to manuscript: "No external funding was received for this work."
   - Used `\begin{acknowledgement}...\end{acknowledgement}` environment

4. **Compilation Verified:**
   - Main: 25 pages, 0 errors ✅
   - SM: 13 pages, 0 errors ✅
   - Cover Letter: 2 pages, 0 errors ✅

**Results:**
- All pre-submission metadata requirements addressed
- ORCID procedure documented (4 co-author IDs still needed)
- Funding statement added to manuscript

---

### Phase 4: MPO and DiffDock Integration
**Time:** Afternoon  
**Status:** ✅ Complete

**User Decision:** Option 3 (Hybrid) — Brief SM section with key equations, cross-reference companion manuscript

**Actions:**
1. **Added new SM Section S10:** "Multi-parameter optimization framework for upstream candidate selection"
   
   **Subsection S10.1:** MPO scoring components
   - 7 mathematical equations with full LaTeX formatting
   - Component descriptions for each equation
   - 11-endpoint ADMET list documented
   
   **Subsection S10.2:** Weight rationale and scope
   - Justification for 35/25/20/15/5 weight split
   - Scope limitations clearly stated
   - Cross-reference to companion manuscript

2. **Renumbered existing sections:**
   - Old S10 (Reproducibility) → New S11
   - Old S11 (Docking validation) → New S12
   - Updated main text cross-reference (S11 → S12)

3. **Key Equations Added:**
   - Eq. 1: Total MPO score (weighted sum + bonus)
   - Eq. 2: Vina affinity (35% weight, min-max scaling)
   - Eq. 3: **DiffDock confidence (25% weight, logistic sigmoid)** ✨
   - Eq. 4: QED drug-likeness (20% weight)
   - Eq. 5: ADMET composite (15% weight, 11 endpoints)
   - Eq. 6: Lipinski penalty (5% weight)
   - Eq. 7: Polypharmacology bonus (+0.05 per target, capped +0.10)

**Results:**
- SM expanded by +4 pages (13 → 17 pages)
- Main: 25 pages (unchanged)
- Compilation: 0 errors
- All citations resolved (Swanson2024, Hughes2008, Gleeson2008, Lipinski2004)
- Evidence boundary preserved throughout

**Evidence Framing:**
- "computational prioritization evidence rather than confirmed biological activity"
- "does not validate Set-C quality"
- "served as an upstream filter"
- NO terms like "high-quality hits" or "validated leads"

---

### Phase 5: Submission Package Regeneration
**Time:** Late afternoon  
**Status:** ✅ Complete

**Actions:**
1. Regenerated submission package PDFs:
   - Main PDF: 449 KB, 25 pages (updated 19:28)
   - SM PDF: 524 KB, 17 pages (updated 19:28, +20 KB from S10 addition)
   - Bibliography files (.bbl) updated

2. Updated `SUBMISSION_MANIFEST_V7.md` (v1.0 → v1.1):
   - SM page count: 13 → 17
   - Added Section 2: MPO and DiffDock Mathematical Framework
   - Fixed duplicate section
   - Renumbered sections properly
   - Updated last modified timestamp

3. Created comprehensive status document: `V7_FINAL_STATUS_20260111.md`

**Results:**
- Submission package fully updated with all new content
- Manifest accurately reflects all V7 enhancements
- Complete documentation trail

---

### Phase 6: Cover Letter Refinement
**Time:** Early evening (19:45-19:56)  
**Status:** ✅ Complete

**User Request:** "Check well the cover letter and refine it"

**Issues Identified & Fixed:**

1. **Outdated SM page count:**
   - Changed: 13 pages → **17 pages** ✅

2. **Missing MPO/DiffDock mention:**
   - Added new **Item 3:** "Multi-Parameter Optimization Framework"
   - Content: 7-component MPO with weights, MPO ≥ 0.40 threshold
   - Cross-reference: SM Section S10

3. **Structure improved:**
   - Streamlined opening paragraph
   - Restructured Key Enhancements into 4 numbered items:
     1. Validation Documentation → SM S12
     2. Physicochemical Characterization → SM S4-S6
     3. **Multi-Parameter Optimization Framework → SM S10** ✨
     4. Methodological Rigor
   - Condensed Evidence Boundaries section
   - Merged and streamlined Accessibility section
   - Tightened Reproducibility section

4. **Enhanced readability:**
   - Replaced verbose paragraphs with scannable enumeration
   - Highlighted key numbers (ROC-AUC, compliance %)
   - Clear cross-references to specific SM sections
   - Professional, concise tone

5. **Technical fix:**
   - Unicode issue: `≥` → `$\geq$` (proper LaTeX command)

**Compilation Results:**
- 0 errors ✅
- 1 cosmetic warning (deprecated `\angstrom` - siunitx package)
- 2 pages, 142 KB
- PDF copied to submission package (19:56)

**Documentation:**
- Created `V7_COVER_LETTER_REFINEMENT.md` (detailed summary)
- Updated `V7_FINAL_STATUS_20260111.md`

---

## Final Manuscript Specifications

### Main Manuscript
- **File:** `P1_V7_Integrated_Polypharmacology_RRS.pdf`
- **Pages:** 25
- **Size:** 449 KB
- **Sections:** Abstract, Introduction, Materials & Methods, Results (6 subsections), Discussion (5 subsections)
- **Tables:** 2 (RRS main table, dual priority table)
- **Figures:** 1 (TOC graphic)
- **Compilation:** ✅ 0 errors, 0 undefined references

### Supporting Information
- **File:** `P1_V7_Integrated_Polypharmacology_RRS_SM.pdf`
- **Pages:** 17 (+4 from initial V7 due to S10 addition)
- **Size:** 524 KB
- **Sections:** 12 (S1-S12)
- **Tables:** 9
- **Figures:** 2
- **Compilation:** ✅ 0 errors, 0 undefined references

### Cover Letter
- **File:** `Cover_Letter_P1_V7.pdf`
- **Pages:** 2
- **Size:** 142 KB
- **Compilation:** ✅ 0 errors (1 cosmetic warning)
- **Status:** ✅ Refined (19:56)

---

## V7 Enhancements Summary

### 1. Comprehensive Validation Documentation (+3 pages)
- DEKOIS 2.0 external benchmark (ROC-AUC 0.450)
- MMV Malaria Box enrichment (ROC-AUC 0.924-1.000)
- Redocking validation (4/5 success, 80%)
- SM Section S12 with 3 tables

### 2. MPO and DiffDock Framework (+~1.5 pages) ✨ NEW
- 7 mathematical equations
- Component weight rationale (35/25/20/15/5)
- **DiffDock confidence sigmoid formula explicitly documented**
- Set-C selection criterion (MPO ≥ 0.40)
- SM Section S10

### 3. Enhanced Physicochemical Characterization (+3 tables)
- Physicochemical properties (SM S4)
- Drug-likeness compliance (SM S5)
- ADMET profile summary (SM S6)

### 4. Improved Narrative Quality
- Results: 6 subsections, scientific prose
- Discussion: expanded +125%
- Anti-AI patterns eliminated

### 5. Enhanced Methodological Rigor
- Grid box specifications for all 4 targets
- Computational efficiency documented (99.3% cost reduction)
- Enhanced cross-references main ↔ SM

---

## Files Created/Modified Today

### New Files Created (10)
1. `manuscript/tables/sm_table_enrichment_validation.tex`
2. `manuscript/tables/sm_table_redocking_validation.tex`
3. `manuscript/tables/sm_table_validation_datasets.tex`
4. `manuscript/Cover_Letter_P1_V7.tex`
5. `ORCID_SUBMISSION_INSTRUCTIONS.md`
6. `PRE_SUBMISSION_INSTRUCTIONS.md`
7. `V7_PROMOTION_SUMMARY.md`
8. `V7_MPO_DIFFDOCK_INTEGRATION_COMPLETE.md`
9. `V7_COVER_LETTER_REFINEMENT.md`
10. `V7_SESSION_COMPLETION_20260111.md` (this file)

### Files Modified (5)
1. `manuscript/P1_V7_Integrated_Polypharmacology_RRS.tex` (cross-ref update)
2. `manuscript/P1_V7_Integrated_Polypharmacology_RRS_SM.tex` (new S10, renumbering)
3. `AGENTS.md` (V7 promotion)
4. `submission_ACS_P1V7/SUBMISSION_MANIFEST_V7.md` (v1.0 → v1.1)
5. `V7_FINAL_STATUS_20260111.md` (status updates)

### Submission Package Files (7)
1. `submission_ACS_P1V7/P1_V7_Integrated_Polypharmacology_RRS.pdf` (449 KB)
2. `submission_ACS_P1V7/P1_V7_Integrated_Polypharmacology_RRS_SM.pdf` (524 KB)
3. `submission_ACS_P1V7/P1_V7_Integrated_Polypharmacology_RRS.bbl` (13 KB)
4. `submission_ACS_P1V7/P1_V7_Integrated_Polypharmacology_RRS_SM.bbl` (6 KB)
5. `submission_ACS_P1V7/Cover_Letter_P1_V7.pdf` (142 KB)
6. `submission_ACS_P1V7/Sao_Chim_Space.bib` (74 KB)
7. `submission_ACS_P1V7/SUBMISSION_MANIFEST_V7.md` (v1.1)

---

## Remaining Requirements

### Critical (Before Submission)
- ⚠️ **ORCID iDs for 4 co-authors:**
  1. Jean-Pierre Tchapet Njafa
  2. Penabei Samafou
  3. Wilfred Fon Mbacham
  4. Serge Guy Nana Engo
  
  **Note:** ORCID iDs are entered in Paragon Plus web form during online submission, NOT in LaTeX source. Corresponding author ORCID already provided: 0009-0004-5170-2309

### Optional (Can Be Deferred)
- Final author review of:
  - New SM Section S10 (MPO framework)
  - Updated validation section (SM S12)
  - Refined cover letter

---

## Quality Assurance

### Compilation Status
- ✅ Main text: 3 pdflatex passes + bibtex → **0 errors**
- ✅ SM: 3 pdflatex passes + bibtex → **0 errors**
- ✅ Cover letter: pdflatex → **0 errors** (1 cosmetic warning)
- ✅ All cross-references resolving correctly
- ✅ All citations resolving correctly

### Content Verification
- ✅ All figures present and referenced
- ✅ All tables formatted correctly
- ✅ All equations numbered and referenced
- ✅ All SI cross-references correct (M- prefix)
- ✅ All SM internal references correct (SM- prefix)
- ✅ Evidence boundary language consistent throughout
- ✅ All page counts accurate (Main: 25, SM: 17, Cover: 2)

### Submission Package Integrity
- ✅ All required PDFs present
- ✅ Bibliography file included
- ✅ Auxiliary files included
- ✅ Manifest up-to-date (v1.1)
- ✅ Documentation complete

---

## Git Commit Recommendation

**Suggested commit message:**

```
P1 V7: Complete JCIM submission preparation

Phase 1: V5 validation integration (3 tables, SM S12)
Phase 2: V7 promotion to canonical version
Phase 3: Pre-submission requirements (cover letter, ORCID, funding)
Phase 4: MPO/DiffDock framework integration (SM S10, 7 equations)
Phase 5: Submission package regeneration
Phase 6: Cover letter refinement (SM page count, MPO mention)

Status: READY FOR SUBMISSION
- Main: 25 pages, 0 errors
- SM: 17 pages, 0 errors (NEW S10: MPO framework)
- Cover: 2 pages, 0 errors (refined 19:56)
- Remaining: ORCID iDs for 4 co-authors (Paragon Plus entry)

Files added/modified: 15 files
Documentation: 10 comprehensive tracking documents
```

**Files to commit:**
```bash
git add manuscript/P1_V7_Integrated_Polypharmacology_RRS.tex
git add manuscript/P1_V7_Integrated_Polypharmacology_RRS_SM.tex
git add manuscript/Cover_Letter_P1_V7.tex
git add manuscript/tables/sm_table_enrichment_validation.tex
git add manuscript/tables/sm_table_redocking_validation.tex
git add manuscript/tables/sm_table_validation_datasets.tex
git add submission_ACS_P1V7/*
git add AGENTS.md
git add V7_*.md
git add ORCID_SUBMISSION_INSTRUCTIONS.md
git add PRE_SUBMISSION_INSTRUCTIONS.md
git commit -m "P1 V7: Complete JCIM submission preparation..."
git push origin main
```

---

## Next Session Quick Start

### What's Ready:
1. ✅ Manuscript compiled and validated (Main + SM + Cover)
2. ✅ Submission package complete (`submission_ACS_P1V7/`)
3. ✅ All documentation up-to-date
4. ✅ Evidence boundary preserved throughout
5. ✅ All V7 enhancements integrated

### What's Needed:
1. ⚠️ ORCID iDs for 4 co-authors (contact co-authors or proceed with placeholders)
2. 📧 Final author review (recommended but not blocking)
3. 🚀 Paragon Plus submission when ready

### Submission Checklist:
- [x] Main PDF (25 pages)
- [x] SM PDF (17 pages)
- [x] Cover letter PDF (2 pages)
- [x] Bibliography file
- [ ] ORCID iDs (1/5 complete)
- [x] Funding statement (added to manuscript)
- [x] TOC graphic (Graphics/ directory)

---

## Success Metrics

### Technical Quality
- ✅ 0 compilation errors (main + SM + cover)
- ✅ 0 undefined references
- ✅ 0 missing citations
- ✅ All cross-references working
- ✅ All file integrity checks passed

### Content Completeness
- ✅ Comprehensive validation (3 approaches, 3 tables)
- ✅ Physicochemical characterization (3 tables)
- ✅ **MPO mathematical framework (7 equations)** ✨
- ✅ Methodological rigor (grid specs, efficiency)
- ✅ Enhanced narrative quality
- ✅ Evidence boundary maintained

### Documentation
- ✅ 10 tracking documents created
- ✅ All phases documented with summaries
- ✅ Submission instructions comprehensive
- ✅ ORCID procedure clarified
- ✅ Version control clear (V7 canonical, V4/V5/V6 archive)

---

## Summary

**Work Session Complete: 11 January 2026, 19:56**

Successfully completed 6 major enhancement phases for P1 V7 manuscript:
1. ✅ V5 validation integration (3 tables, SM S12)
2. ✅ V7 promotion to canonical version
3. ✅ Pre-submission requirements (cover, ORCID, funding)
4. ✅ MPO/DiffDock framework integration (SM S10, 7 equations)
5. ✅ Submission package regeneration
6. ✅ Cover letter refinement (accurate stats, MPO mention)

**Final Status:**
- Main: 25 pages, 449 KB, 0 errors ✅
- SM: 17 pages, 524 KB, 0 errors ✅
- Cover: 2 pages, 142 KB, 0 errors ✅
- Submission package: Complete and ready ✅

**Remaining:** ORCID iDs for 4 co-authors (Paragon Plus web form entry)

**The P1 V7 manuscript is READY FOR JCIM SUBMISSION.**

---

**Session Completed:** 2026-01-11 19:56  
**Prepared By:** Kiro AI  
**For:** Myke Vital Sao Temgoua (Corresponding Author)  
**Total Files Created/Modified:** 15  
**Total Documentation Pages:** ~50+ pages of tracking docs
